Portland, OR, March 04, 2019 (GLOBE NEWSWIRE) -- Allied Market Research recently published a report, titled, “Head & Neck Cancer Drugs Market by Drug Class (Chemotherapy, Immunotherapy, and Targeted Therapy) and Sales Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Stores): Global Opportunity Analysis and Industry Forecast, 2018–2025”. According to the report, the global head & neck cancer drugs market accounted for $1.30 billion in 2017 and is projected to $2.28 billion by 2025, registering a CAGR of 7.3% during the period from 2018 to 2025.
Segmentation Analysis of the Industry
The market is divided on the basis of drug class, sales channel, and geography. Based on drug class, the market is segmented into chemotherapy, immunotherapy, and targeted therapy. The chemotherapy segment held the largest share in 2017, contributing nearly half of the total market share. However, the immunotherapy segment is expected to manifest the fastest CAGR of 12.1% during the forecast period.
Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/5174
On the basis of sales channel, the market is divided into hospital pharmacies, drug stores & retail pharmacies, and online stores. The drug stores & retail pharmacies segment dominated the market in terms of revenue, contributing about 58% of the total market share in 2017. However, the online stores segment is projected to portray the fastest CAGR of 10.2% through 2025.
Based on geography, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa (LAMEA). North America region held the largest share in 2017, accounting about half of the total market. However, Asia-Pacific region is estimated to manifest the fastest CAGR of 9.7% during the forecast period.
Industry Key Players
The report includes the major market players in the industry, such as AstraZeneca PLC, Eli Lilly and Company (ARMO Biosciences), F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Merck & Co., Inc., Novartis AG, Bristol-Myers Squibb Company, Fortress Biotech, Inc. (Checkpoint Therapeutics, Inc.), Immutep Limited, Merck KGaA (EMD Serono, Inc.), and Pfizer Inc.
Browse Similar Reports:
Cancer Vaccines Market - Global Opportunity Analysis and Industry Forecast, 2017-2023
Cancer Gene Therapy Market - Global Opportunity Analysis and Industry Forecast, 2017-2023